MicroRNA-29a Is a Candidate Biomarker for Alzheimer’s Disease in Cell-Free Cerebrospinal Fluid

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1559-1182
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
MicroRNA-29a Is a Candidate Biomarker for Alzheimer’s Disease in Cell-Free Cerebrospinal Fluid ; volume:53 ; number:5 ; day:21 ; month:4 ; year:2015 ; pages:2894-2899 ; date:7.2016
Molecular neurobiology ; 53, Heft 5 (21.4.2015), 2894-2899, 7.2016

Urheber
Müller, Mareike
Beteiligte Personen und Organisationen
Jäkel, Lieke
Bruinsma, Ilona B.
Claassen, Jurgen A.
Kuiperij, H. Bea
Verbeek, Marcel M.
SpringerLink (Online service)

DOI
10.1007/s12035-015-9156-8
URN
urn:nbn:de:1111-2016061118994
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:48 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Müller, Mareike
  • Jäkel, Lieke
  • Bruinsma, Ilona B.
  • Claassen, Jurgen A.
  • Kuiperij, H. Bea
  • Verbeek, Marcel M.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease

Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients

Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients

Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease

Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease

Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease

Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease

Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease

Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease

Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease

Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease

Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease

Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease

Verbundene Objekte